Aspira Women's Health Inc.
AWHL· OTC
Released Mar 28, 2024, after the close
10-K filed Apr 1, 2024, 92 days after period end · 0000926617-24-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.13M | $2.15M | $1.85M | $1.45M |
| Net Income | -$3.09M |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$4.59M |
| -$8.96M |
| -$6.08M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.